SCHEDULE 13G/A: L1 Capital Global Opportunities Master Fund Discloses 4.99% Stake in Incannex Healthcare Inc.
Beneficial Ownership Report
L1 Capital Global Opportunities Master Fund, Ltd. has filed an amended Schedule 13G, reporting a 4.99% beneficial ownership stake in Incannex Healthcare Inc. as of March 31, 2025.
Summary
- L1 Capital Global Opportunities Master Fund, Ltd., a Cayman Islands-based entity, filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in Incannex Healthcare Inc.
- The filing reports beneficial ownership of 1,468,747 Series A Common Warrants in Incannex Healthcare Inc.
- This ownership represents 4.99% of the Common Stock class, based on 29,433,798 Common Stock outstanding as of May 13, 2025.
- The reported warrants are subject to a 4.99% beneficial ownership limitation, and an additional 460,268 Series A Common Warrants are not included due to this limitation.
- L1 Capital Global Opportunities Master Fund, Ltd. holds sole voting and sole dispositive power over the 1,468,747 warrants.
- Directors David Feldman and Joel Arber are associated with L1 Capital Global Opportunities Master Fund, Ltd. and disclaim beneficial ownership of these securities except to the extent of their pecuniary interest.
- The securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently suggest a positive or negative sentiment towards the issuer's performance or outlook.
Risks
- The Series A Common Warrants held by L1 Capital Global Opportunities Master Fund, Ltd. are subject to a 4.99% beneficial ownership limitation, which restricts the fund's ability to increase its stake beyond this threshold without triggering additional disclosure requirements or potential control implications.
- Directors David Feldman and Joel Arber disclaim beneficial ownership of the securities except to the extent of their pecuniary interest, which clarifies their indirect control over the shares.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding the issuer's future performance or strategic direction.
Industry Context
This filing is a standard disclosure of a significant ownership stake by an investment fund in a publicly traded company. It reflects an investment decision by L1 Capital Global Opportunities Master Fund, Ltd. in Incannex Healthcare Inc., a company in the healthcare sector, without providing broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake in the company, which can influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement (beneficial ownership stake). |
| 05/13/2025 | Date as of which the Issuer's Common Stock outstanding (29,433,798 shares) was reported in their Form 10-Q. |
| 05/15/2025 | Date the Schedule 13G Amendment No. 1 was signed and filed with the SEC. |
Keywords
Incannex Healthcare Inc., L1 Capital Global Opportunities Master Fund, Schedule 13G, Beneficial Ownership, Common Stock, Series A Common Warrants, SEC Filing, Investment Fund, Shareholding, IHL
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.